U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070921) titled 'Assessing Safety and Performance of the Novel CytaCoat Foley Catheter' on June 03.
Brief Summary: This study is a prospective, single-center, single-blind, randomized, parallel assignment, controlled study to evaluate the safety and performance of the novel CytaCoat Foley catheter when compared to a Sterimed uncoated Foley catheter. Participants will include male and female adult subjects who require an indwelling urinary catheter for an expected duration of minimum 72 hours to 14 days.
The primary purpose of the clinical investigation is to determine whether the novel CytaCoat Foley catheter is safe to use in subjects. Safety is a...